Top Equity Movers of the Pre-Market:
RHT +10% Announced Earnings, Beat on EPS and Revenue
IMNP +9% Announced initiation of enrollment in clinical trial with Ceplene®/ low-dose IL-2 in Chronic Myelomonocytic Leukemia (CMML)
SGMO -8% Announces Proposed Public Offering of Common Stock
RUN –2% Announced Florida solar access initiatives earlier this week